Enanta Pharmaceuticals Q1 Earnings: Snapshot Analysis

by Dr Natalie Singh - Health Editor
0 comments

Enanta Pharmaceuticals Inc. (ENTA) on Monday reported a loss of $11.9 million in its fiscal first quarter.

WATERTOWN, Mass.(AP) — WATERTOWN, Mass. (AP) — Enanta Pharmaceuticals Inc. (ENTA) on Monday reported a loss of $11.9 million in its fiscal first quarter.

On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of 42 cents.

The biotechnology company posted revenue of $18.6 million in the period.

This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ENTA at

Copyright 2025 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

date: 2026-02-09 21:28:00

Related Posts

Leave a Comment